Detalhe da pesquisa
1.
Axion Dark Matter Experiment: Detailed design and operations.
Rev Sci Instrum;
92(12): 124502, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972408
2.
EUFOREA treatment algorithm for allergic rhinitis.
Rhinology;
58(6): 618-622, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991658
3.
Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.
Allergy;
73(9): 1842-1850, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512827
4.
EAACI guidelines on allergen immunotherapy: Executive statement.
Allergy;
73(4): 739-743, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380390
5.
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.
Allergy;
73(6): 1254-1262, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29322510
6.
EAACI Position paper on the standardization of nasal allergen challenges.
Allergy;
73(8): 1597-1608, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377177
7.
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.
Allergy;
73(4): 765-798, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940458
8.
Practice and safety of allergen-specific immunotherapy for allergic rhinitis in the UK national health service: A report of "real world" clinical practice.
Clin Exp Allergy;
48(1): 89-92, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29108101
9.
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
Allergy;
73(4): 896-904, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150857
10.
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.
Allergy;
72(11): 1597-1631, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28493631
11.
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
Allergy;
72(8): 1156-1173, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152201
12.
Novel approaches and perspectives in allergen immunotherapy.
Allergy;
72(7): 1022-1034, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122129
13.
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).
Clin Exp Allergy;
47(7): 856-889, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239057
14.
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper.
Allergy;
72(5): 713-722, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27874202
15.
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.
Clin Transl Allergy;
6: 41, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895895
16.
Pathogenesis of rhinitis.
Clin Exp Allergy;
46(9): 1139-51, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27434218
17.
Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.
Allergy;
71(9): 1345-56, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27184158
18.
T follicular helper (Tfh ) cells in normal immune responses and in allergic disorders.
Allergy;
71(8): 1086-94, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970097
19.
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibody.
Allergy;
71(1): 36-46, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26221749
20.
Loss of adaptation following reversion suggests trade-offs in host use by a seed beetle.
J Evol Biol;
28(10): 1882-91, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26201813